Society of Scholars Inducts New Members
The Society of Scholars was created on the
recommendation of former president Milton S. Eisenhower and
approved by the university board of trustees on May 1,
1967. The society — the first of its kind in the
nation — inducts former postdoctoral fellows and
junior or visiting faculty at Johns Hopkins who have gained
marked distinction in their fields of physical, biological,
medical, social or engineering sciences or in the
humanities and for whom at least five years have elapsed
since their last Johns Hopkins affiliation. The Committee
of the Johns Hopkins Society of Scholars, whose members are
equally distributed among the academic divisions, elects
the scholars from the candidates nominated by the academic
divisions that have programs for postdoctoral fellows.
The scholars elected in 2006 will be invested at a
ceremony hosted by Provost Steven Knapp at 4 p.m. on
Wednesday, May 24, at Evergreen House. At that time, the
new members will be presented with a diploma and a
medallion on a black and gold ribbon. The induction —
which brings to 490 the total number of members in the
Johns Hopkins Society of Scholars — will be followed
by a dinner hosted by President William R. Brody. The new
members will be recognized at Commencement on May 25.
The following listing gives a short description of the
new inductees' accomplishments at the time of their
election to the society, their affiliation at Johns Hopkins
and the name of their nominator.

Stylianos Antonarakis, Geneva

Stylianos Antonarakis
|
Stylianos Antonarakis is widely known for his research
in genetic mutations that cause several hereditary
conditions, such as hemophilia and thalassemia, and in Down
syndrome, a disorder of chromosome number. He is the chair
of the Department of Genetic Medicine and Development in
the University of Geneva Medical School in Switzerland. His
department is recognized for its active role in research,
teaching and patient care. Antonarakis spent from 1980 to
1983 as a postdoctoral fellow in the Johns Hopkins
Department of Pediatrics and in the Center of Medical
Genetics (now the McKusick-Nathans Institute of Genetic
Medicine). He was nominated by Victor McKusick, University
Professor of Medical Genetics in the Department of
Medicine.

Henry Bohlman, Cleveland

Henry Bohlman
|
A professor of orthopedic surgery at Case Western
Reserve University in Cleveland, Henry Bohlman is widely
recognized as a leader in the understanding and treatment
of cervical spine pathology, a focus he developed as a
Johns Hopkins resident working under Robert A. Robinson,
chair of Orthopaedic Surgery, between 1964 and 1970. Since
then, Bohlman has not only clarified the epidemiology and
etiology of cervical spine injuries, but he also has
written seminal works on the anatomy and biomechanics of
those injuries. Equally important is the role he has played
in providing important training and mentoring for today's
spine surgery leaders. In fact, virtually every leader in
this field today trained at some point with Bohlman. That
work continues today. Bohlman was nominated by Paul
Sponseller, professor and chief of the Pediatric Division
of the Department of Orthopaedics and vice chair of the
Department of Orthopaedic Surgery.

Daniel Denegri, Gif-sur-Yvette, France

Daniel Denegri
|
Following his postdoctoral work from 1969 to 1971 in
the Johns Hopkins Department of Physics and Astronomy,
Daniel Denegri joined the international team that
discovered the W and Z particles, the long-sought carriers
of the weak nuclear force, establishing the Standard Model
of Particle Physics. Considered one of the greatest
scientific breakthroughs of the 20th century, the discovery
garnered the Nobel Prize for physics in 1984. Denegri
played a major role in that discovery, building a key part
of the instrument that detected the new particles. Denegri
is currently working to extend the theory as a research
director at the Commissariat à l'Energie Atomique in
Saclay, France, near Paris. He was nominated by Jonathan
Bagger, Krieger-Eisenhower Professor and chair of Physics
and Astronomy.

Daniel Driscoll, Gainesville, Fla.

Daniel Driscoll
|
Daniel Driscoll is one of the best of the vanishing
breed known as physician/scientists. His meticulous studies
of patients with Angelman and Prader-Willi syndromes are
considered milestones in the burgeoning field of
epigenetics. Many consider Driscoll the premier
clinician/scientist for the care of those with Prader-Willi
syndrome, a genetic cause of obesity. In fact, Driscoll
devised a method that is now considered the gold standard
for diagnosing the syndrome, and he characterized the
mutations that are responsible for the disease. Today, he
is training both scientists and clinicians at the
University of Florida College of Medicine, where he is a
professor of pediatrics and genetics and the John T. and
Winifred M. Hayward Professor in Genetics Research.
Driscoll was at Johns Hopkins for a residency from 1983 to
1986 and on a fellowship from 1986 to 1989. His nominator
was Barbara Migeon, professor in the McKusick-Nathans
Institute of Genetic Medicine and the Department of
Pediatrics.

Donald Gilden, Denver

Donald Gilden
|
Long after a bout of the chicken pox fades, the
varicella-zoster virus that causes the illness lingers in
the human nervous system. At the University of Colorado
Health Sciences Center, where he is the Louise Baum
Professor and Chair of Neurology, Donald Gilden studies the
impact of the latent virus. A second important project led
by Gilden uses a molecular approach to understand and
define immune system responses in multiple sclerosis with
the ultimate goal of being able to pinpoint the antigens
responsible for the disease. A native of Baltimore, Gilden
came in 1969 to the Department of Epidemiology at the Johns
Hopkins School of Hygiene and Public Health (now the
Bloomberg School of Public Health), where he spent two
years as an NIH postdoctoral fellow. He was nominated by
Richard Johnson, Distinguished Service Professor of
Neurology, Microbiology and Neuroscience.

Chih-Ming Ho, Los Angeles

Chih-Ming Ho
|
Chih-Ming Ho is an expert on nano-fluidic technologies
and the wide spectrum of biotech and nanotech applications,
such as gene sensing, drug discovery and health
maintenance. One of the most frequently cited engineering
researchers in the world, he has published 220 papers and
holds seven patents. Ho is associate vice chancellor for
research for engineering and physical sciences at the
University of California, Los Angeles, where he helped
establish a micro-electro-mechanical system program that is
recognized as one of the best in the field. He was inducted
into the National Academy of Engineering in 1997. At Johns
Hopkins, he was an associate research scientist from 1974
to 1975 in what is now the Department of Mechanical
Engineering. He was nominated by Tza-Huei "Jeff" Wang,
assistant professor in the Department of Mechanical
Engineering.

Michael Kaback, San Diego

Michael Kaback
|
A professor in the Department of Pediatrics and
Reproductive Medicine at the University of California, San
Diego, Michael Kaback is considered a world leader in the
understanding and treatment of a genetic disorder known as
Tay-Sachs disease, which affects primarily people of
Ashkenazi Jewish descent. In 1971 — a year after
research led to the understanding of the biochemical basis
of Tay-Sachs — Kaback produced an effective test to
detect carriers of this disease and conducted Maryland's
first mass public screening. He then spearheaded a national
campaign to educate targeted populations about the
importance of genetic screening, an action that resulted in
far fewer cases of this uniformly fatal disease. Kaback was
at Johns Hopkins from 1963 to 1968 as an intern and
resident on the Harriet Lane Service and on the faculty of
the Department of Pediatrics. In 1991, he was the American
College of Medical Genetics' Founding Fellow. He was
nominated for the Society of Scholars by Aravinda
Chakravarti, the Henry J. Knott Professor and Director of
the McKusick-Nathans Institute of Genetic Medicine and
professor of medicine, pediatrics and molecular biology and
genetics.

Michael Kastan, Memphis, Tenn.

Michael Kastan
|
While at Johns Hopkins as a new assistant professor,
Michael Kastan discovered that a certain protein, p53,
functions as a "guardian of the genome," causing cells to
pause and repair damage to their DNA before going on to
divide. As p53 is the most commonly mutated gene in human
cancer, this work has enormous implications for cancer
prevention, diagnosis and treatment. Kastan served as an
intern, resident and fellow in the departments of
Pediatrics and Oncology at Johns Hopkins from 1984 to 1989.
He then joined the Johns Hopkins faculty, working in the
departments of Oncology, Pediatrics, and Molecular Biology
and Genetics until he moved to St. Jude Children's Research
Hospital in Memphis in 1998. Kastan is now chairman of the
Department of Hematology/Oncology and director of the
Cancer Center at St. Jude. He was nominated for the Society
of Scholars by Martin Abeloff, the Marion I. Knott
Professor and Director of the Sidney Kimmel Comprehensive
Cancer Center, and Curt Civin, the Herman and Walter
Samuelson Professor of Oncology and co-director of the
Immunology and Hematopoiesis Division.

Jay Knutson, Bethesda, Md.

Jay Knutson
|
Jay Knutson is a leader in the development of
laser-driven high-speed optical instruments and techniques
used in the life sciences. Most recently, he applied
femtosecond lasers to the study of water organization
around proteins, the binding of DNA-controlling receptors
inside cell nuclei and the energy production process within
heart cells. Knutson's technical innovations have allowed
researchers to make advances in the fields of biology and
medicine. From 1980 to 1984, he was a postdoctoral fellow
in the Department of Biology at Johns Hopkins. Today, he is
chief of the Optical Spectroscopy Section of the Laboratory
of Biophysical Chemistry of the National Heart, Lung and
Blood Institute at the National Institutes of Health. He
was nominated by Ludwig Brand, professor in the Department
of Biology.

Athan Kuliopulos, Boston

Athan Kuliopulos
|
Athan Kuliopulos is best known for his work
identifying an enzyme that activates a receptor that
results in cancer cell invasion and tumor growth.
Kuliopulos' team was then able to block the spread of
breast cancer in animals using special compounds that act
on the inside surface of the cell, downstream from the
enzyme and receptor. Now an associate professor of
medicine, biochemistry and genetics and director of the
Hemostasis and Thrombosis Laboratory at Tufts New England
Medical Center in Boston, Kuliopulos was a postdoctoral
student in the Department of Biological Chemistry and the
Department of Pharmacology and Molecular Sciences at Johns
Hopkins from 1989 to 1990. He was nominated by Albert
Mildvan, professor emeritus of biological chemisty and
chemistry; Paul Talalay, the John Jacob Abel Distinguished
Service Professor of Pharmacology; and Philip Cole, the
E.K. Marshall and Thomas H. Maren Professor of Pharmacology
and director of Pharmacology and Molecular Sciences.

Elaine Larson, New York

Elaine Larson
|
A leading clinical researcher and nurse educator,
Elaine Larson is internationally known for her work in
infection control and epidemiology. She is considered one
of the experts in the field of hand hygiene and has become
a leading authority on the use — and misuse —
of antibacterial products. Her service on federal
committees and presidential and congressional commissions
has laid the groundwork for national policy on the use of
antimicrobials and for funding of nursing research and
management of HIV infection and Gulf War veterans'
illnesses. From 1985 to 1992, Larson was affiliated with
the Johns Hopkins School of Nursing and the Department of
Epidemiology in the School of Hygiene and Public Health
(now the Bloomberg School of Public Health). Today, Larson
is a professor of pharmaceutical and therapeutic research
and associate dean for research at Columbia University
School of Nursing and a professor of epidemiology at
Columbia's Joseph Mailman School of Public Health. She was
nominated by Martha Hill, professor and dean of the School
of Nursing.

Liming Lee, Beijing
Liming Lee is a prominent leader in public health and
medicine in the People's Republic of China. Following
postdoctoral studies in the Department of Epidemiology at
Johns Hopkins in 1991-1992, he served as the dean of the
Peking University School of Public Health from 1997 to
2000. As president of the Chinese Academy of Preventive
Medicine from 2000 to 2002, Lee led the mission to
establish China's Centers for Disease Control and
Prevention and was appointed founding director in 2002.
Currently a professor of epidemiology at Peking University
Health Science Center in Beijing, Lee gained international
acclaim when he spearheaded the herculean effort to control
the SARS epidemic in China. He was nominated by Guohua Li,
professor in the Department of Emergency Medicine.

Mark Orringer, Ann Arbor, Mich.

Mark Orringer
|
Mark Orringer specializes in lung cancer surgery,
esophageal cancer surgery and the diagnosis and treatment
of chest wall tumors. His research focuses on improving
methods of esophageal removal and replacement, as well as
combined therapies for esophageal cancer and lung cancer.
After completing his general surgery and thoracic surgery
residencies at Johns Hopkins between 1967 and 1973,
Orringer joined the faculty at the University of Michigan,
where he has served as the head of General Thoracic Surgery
since 1985. For more than 20 years, he has been an
excellent teacher and mentor for medical students and
surgical residents, and an outstanding clinical thoracic
surgeon. He was nominated by Julie Freischlag, the William
Steward Halsted Professor and director of the Department of
Surgery.

Raymond Roos, Chicago

Raymond Roos
|
Raymond Roos is a nationally recognized researcher and
leading clinician in the field of neurodegenerative
disorders, particularly amyotrophic lateral sclerosis,
multiple sclerosis and prion diseases. He spent 1971 to
1976 at the Johns Hopkins School of Medicine, first as a
resident and then as a postdoctoral fellow in virology and
immunology. Now a professor in the Department of Neurology
at the University of Chicago, where he was department
chairman from 1996 to 2004, Roos is considered an authority
on the relationship between viral infection and
neurological disease. He has edited one book and authored
or co-authored more than 100 research articles in
peer-reviewed journals, nearly 50 book chapters and more
than 150 abstracts. A highly respected clinical neurologist
and teacher, both at the bedside and at the bench, Roos has
been consistently funded by NIH and voluntary agencies for
his research, and he is an outstanding example of the
complete clinician/teacher/investigator. He was nominated
by Richard Johnson, Distinguished Service Professor of
Neurology, Microbiology and Neuroscience.

David Serwadda, Kampala, Uganda

David Serwadda
|
During his first year of residency, David Serwadda
investigated an outbreak of a new disease in southwestern
Uganda. In doing so, he was the first to recognize slim
disease, or AIDS, in East Africa. This led Serwadda to a
lifelong commitment to HIV prevention and sowed the seeds
of what would, in 1987, become the internationally
recognized Rakai Health Sciences Program, which has made
major contributions to the epidemiology, basic science and
clinical science needed for the control of HIV in
sub-Saharan Africa. One of the program's collaborators is
Johns Hopkins, where Serwadda was a postdoctoral fellow and
earned his master's degree in public health in 1991. Today,
he is director of the Makerere University Institute of
Public Health in Uganda, the premier school of public
health in sub-Saharan Africa. He was nominated for the
Society of Scholars by Ronald Gray, professor in the
Department of Population and Family Health Sciences.
GO TO MAY 22, 2006
TABLE OF CONTENTS.
GO TO THE GAZETTE
FRONT PAGE.
|